Facetten
Zugriff
Einrichtung
Medientyp
- Text 7
Karte
Erscheinungsjahr
Autor/in
- Ettl, Johannes
- Fasching, Peter A
- Lüftner, Diana
- Hadji, Peyman 5
- Hartkopf, Andreas D 5
- alle zeigen
Sprache
- Englisch 7
7 Einträge gefunden
-
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry
- Müller, Volkmar
- Hein, Alexander
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
-
Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT
- Engler, Tobias
- Fasching, Peter A
- Lüftner, Diana
- Hartkopf, Andreas D
- Müller, Volkmar
- Kolberg, Hans-Christian
- Hadji, Peyman
-
Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
- Schneeweiss, Andreas
- Ettl, Johannes
- Lüftner, Diana
- Beckmann, Matthias W
- Belleville, Erik
- Fasching, Peter A
- Fehm, Tanja N
-
ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results
- Untch, Michael
- Würstlein, Rachel
- Lüftner, Diana
- Haidinger, Renate
- Fasching, Peter A
- Augustin, Doris
- Briest, Susanne
-
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
- Michel, Laura L
- Hartkopf, Andreas D
- Fasching, Peter A
- Kolberg, Hans-Christian
- Hadji, Peyman
- Tesch, Hans
- Häberle, Lothar
-